Soco, Ozia Samuel George M.

HRN: 22-33-48  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2022
AMPICILLIN 250MG (VIAL)
12/22/2022
12/29/2022
IV
170mg
Q12
NEonatal Sepsis
Waiting Final Action 
12/22/2022
CEFTAZIDIME 1GM (VIAL)
12/22/2022
12/29/2022
IV
170mg
Q8h
Neonatal Sepsis
Waiting Final Action 
12/26/2022
MUPIROCIN 2%, 15G (TUBE)
12/26/2022
01/01/2023
DERMAL
-
TID
Omphalitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: